基本信息
浏览量:2
职业迁徙
个人简介
João Gomes performed is BsC in Biochemistry at the University of Coimbra, Portugal, in 2004. He performed his graduation internship in the clinical pathology unit of the Portuguese Institute of Oncology, but the Neuroscience field excitement was stronger. So, he moved to the Neurotrophin Signalling and Brain DysFunction Group headed by Prof. Carlos Duarte, at Center for Neuroscience and Cell Biology, Coimbra. He concluded his PhD (2011) in this group, focusing in growth factor signaling in both physiologic and pathologic conditions (brain ischemia), which led to the identification of molecular signaling mechanisms behind BDNF neuroprotection. He also unraveled how vesicular transporters (VGAT and VGLUTs) are affected in ischemic conditions, influencing excitotoxic neuronal cell death and potentially brain ischemia. Both works produced two papers in the prestigious Journal of Neurosciences, one was selected for cover and awarded Best Article by the Portuguese Society for Neurosciences. During his PhD, João had the opportunity to work abroad in Lund, Sweden, at the Wallenberg Neuroscience Center, in the Laboratory for Experimental Brain Research, headed by Tadeuz Wieloch, where he learned an in-vivo stroke mice model, tMCAO. He established the model at CNC, and later at IBMC. After his PhD, he moved to IBMC, to proceed with post-doctoral studies at the Molecular Neurobiology Group head by Maria J. Saraiva. In his 1st Postdoct, he worked in collaboration with the pharmaceutical company Ablynx, studying different routes to target CNS, using nanobodies. He also started his independent work in the study of Transthyretin physiology. Then, in his 2nd Postdoc, João unraveled the molecular pathways involving TTR in CNS neurons, in physiologic and ischemic conditions, establishing TTR as a new neurotrophic factor.
Presently, he is a research assistant at the Molecular Neurobiology Group in I3S, running 2 project grants as Principal Investigator (one as co-PI): a translation project to unveil biomarkers for diagnosis and management of acute ischemic stroke; a project aiming to use CRISPR/Cas9 TTR gene editing conjugated with lipid nanoparticles as a tool to achieve a conditional TTR KO mice model in CSF and Sera independently, in collaboration with the pharmaceutical company Intellia Therapeutics. Moreover, he has been an ad hoc reviewer in several scientific journals such as: Neurochemical Research, Pharmacological Research, Frontiers in Neurology. Since he arrived Maria Saraiva Lab (2010), he has been developing his independent research line in the stroke field.
João is starting to consolidate his early carrier: by managing his team (completed supervision of 2 MSc and 1 Post-Doc); secure funding (1 FCT project (190k) as PI; 1 project with pharmaceutical company Intellia (35k); 1 contract to secure 1 Master researcher for his team(6,2k); 1 paper as corresponding author, and 2 working papers as last author in the stroke field. He had 2 shared paternity leaves (2015, 2017).
Regarding publications, he is currently (January 2021) author in 18 publications (15 papers: 7 as 1st author, 2 book chapters, 1 conference paper). More than 700 citations and h-index=12. IF of all publications between 4 and 8.3 (two J. of Neuroscience and one Cell Death & Differentiation). He has also recently published in BRAIN Communications as corresponding author, and has 2 working papers as last author.
研究兴趣
论文共 88 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical Neurology and Neurosurgerypp.108356, (2024)
Gustavo Pradilla,Jonathan J Ratcliff,Alex J Hall,Benjamin R Saville,Jason W Allen, Giorgio Paulon,Anna McGlothlin,Roger J Lewis,Mark Fitzgerald, Angela F Caveney,Xiao T Li,Mark Bain,
OPERATIVE NEUROSURGERYno. 5 (2023): 408-416
Critical Care Medicineno. 1 (2023): 266-266
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn